An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia ...

Ambroxol – a common cough medicine in Europe – may prevent the progression of dementia in patients with Parkinson's disease, a new trial suggests.

A common cough syrup, Ambroxol, has shown potential in slowing the progression of Parkinson's dementia in a recent clinical trial.

Common cough medicine could slow dementia in Parkinson’s patients, study hints. Cough medicine widely used in Europe remains unapproved for use in US, Canada, researchers say ...

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop the memory-destroying disease. Around 145,000 people in the UK hav… ...

Parents, guardians and all who care for kids should check their medicine cabinets after a children’s cough syrup was recalled ...

Whooping cough, or pertussis, may sound like a disease from the past, but it is making a comeback. Adults are often the ones ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...